The test can be performed as often as necessary, without the cost and risks involved with radiation from scans, hospitalisation, anaesthesia or painful surgical biopsies.
Benefits:
- Get peace of mind & monitor your cancer diagnosis
- No GP referral required
- No waiting lists
- Consultation with Oncologist
Who can take the Cancertrack™ blood test?
Individuals who have been:
- Diagnosed with cancer
- Undergoing anticancer treatments
- In remission or a cancer survivor seeking recurrence monitoring. (*Recurrence Monitoring only for individuals in remission.)
- Patients in whom the cancer is not responding satisfactorily to ‘Standard of Care’ therapy.
How does the process work?
- Book and pay for your consultation with Oncologist Dr Cheng Boon to ensure suitability for the test.
- If suitable, book your Cancertrack™ test – in clinic or at home with a nurse visit.
- Attend your appointment.
- Receive your results within 12 working days.
What does Cancertrack™ tell you?
Cancer is best managed by a treatment plan that stays one step ahead of the tumour. However, some techniques like scans or imaging can take much longer to detect how quickly or if the treatment is working. That is why it is important to determine as quickly as possible if the cancer is responding to the treatment.
Cancertrack™ can offer this detailed information. Including indication of:
- Targetable molecular alteration
- Any cancerous activity in the body
- Molecular dynamic in real-time
- How successful the therapy is
- Signs of drug resistance
How the test works:
By isolating circulating tumour components (CTCs, DNA, and RNA) from a simple blood sample, Cancertrack™ analyses and deciphers the molecular dynamics and characteristics of the tumour. This process, especially crucial for recurrence monitoring, provides insights into the evolving nature of the malignancy.
Why Choose Cancertrack™?
Cancertrack™ serves as a comprehensive tool to detect dangerous cancer activity, offering a detailed overview of cancer burden, treatment response, and potential drug resistance mechanisms. Key advantages include:
- Non-invasive: A safe, accurate, and cost-effective blood test.
- Not reliant on tissue availability, eliminating barriers.
- Tests all active disease sites
- Information Rich: Surpasses standard tissue biopsy and HPE at diagnosis.
- NCCN Recommended Biomarkers: Extensive coverage of National Comprehensive Cancer Network (NCCN) recommended biomarkers.
- Tumour Heterogeneity: Unaffected by tumour heterogeneity, ensuring reliability.
- Real-time Status: Provides relevant, real-time information on tumour status.
- Frequency: Can be easily performed as often as required.
- Precision: Ultra-sensitive, precise, and accurate results
When will I get my results?
The results are typically returned to you via email within 12 working days of reaching the lab.
What Sets Cancertrack™ Apart?
Cancertrack™ is a comprehensive blood test that delves into the molecular intricacies of cancer through the analysis of circulating tumour DNA, circulating tumour RNA, and the evaluation of Circulating Tumour Cells (CTCs). Real-time monitoring becomes a reality, offering a dynamic understanding of cancer burden, molecular dynamics, treatment response, and emerging resistance.
